Honeywell Humidifier

Although medical science has developed considerably in recent decades is the treatment of leukemia remains a major problem at present. Modern medicine, not a cure for leukemia and medical treatment in those days, the differing results. Survival rates depend on the speed of diagnosis, treatment type and patient response to cancer therapies and treatments. Although leukemia is not fully overcome, the progression ofMalignant disease may be slower and its effects can use existing cancer therapies to be included. For example, life expectancy of patients with leukemia has increased over the past three decades. In contrast, the mortality rate of patients registered with leukemia, a significant decrease in the last ten years has known.

The treatment of leukemia is to achieve a complete remission with minimal side effects are concentrated. Complete remission refers to the absence of leukemiaFootprints on the cellular level. Patients who currently have no evidence of active malignant cells after treatment for leukemia will be fully cured. On the contrary, shows a recurrence of leukemia recurrence of symptoms and physiological signs.

For patients with acute leukemia, remission lasting more than five years after treatment, indicating a full recovery. This period of five years applies to patients with leukemia, and criticismIt can mean the difference between full recovery and recurrence.

In recent decades, the five-year survival for patients with leukemia has tripled. While in the 60s, the rate of five-year survival was approximately 15 percent, which turns about 50 percent. The survival rate five years is strongly influenced by patient age and type of leukemia. Statistics show that) the rate of five-year survival for patients with acute lymphoblastic leukemia (ALL, about 60 percent,During the five year survival rate for patients with chronic lymphocytic leukemia (CLL) is higher, reaching a value of 70 percent. However, the prognosis of patients with myeloid leukemia is less favorable. The five same survival rate for patients with acute myeloid leukemia (AML) is diagnosed about 14 percent, while estimated that more than 32 percent of patients with chronic myeloid leukemia (CML) in this period of five years survival.

The survival rate for children five yearsdiagnosed with acute lymphoblastic leukemia revolves around the value of 80 percent, while overall survival of children with acute lymphoblastic leukemia is less than 45 percent. This type of leukemia is the most common form of cancer diagnosed in children. Due to the fact that it refers in particular to young patients 3 to 15, the disease is a childhood leukemia.

In the United States, the mortality rate of children with leukemia decreased from 60Percent in the last three decades. Although this fact is leukemia remains the leading cause of death in patients younger than 15 years.